Overview

ri:val is a modular solution for the financial valuation and risk management of drug development projects, licenses, pipelines, technologies, companies, and investment portfolios.

The user-friendly framework guides you step-by-step through the valuation process. Save time and energy when looking for industry data or when building complex valuations in Excel because they’re built right in. ri:val allows modification and expansion of every valuation in any scenario. ri:val proposes all the relevant data for the valuation and can export all calculations into Excel.

ri:val standardizes and streamlines the valuation process and keeps topnotch valuation expertise at the fingertips of the entire team.

The results ensure a thorough understanding when making licensing decisions, when performing portfolio reviews, or when investing in biotech or pharma.

ri:val Benefits

• Standardized and comparable valuations
• Expert valuations
• Access to world-class valuation expertise
• Time saving
• Error free
• Backed by industry data
• Reproducible
• User friendly
• Guided valuation process
• Valuations easy to expand or to include in other valuations
• Professional visualization of results
• Full support for valuation questions by industry leaders
  
  

ri:val Features

• Project valuation
• License contract valuation
• Pipeline valuation
• Technology valuation
• Company valuation
• Risk adjusted net present value (rNPV)
• Real options valuation
• Monte Carlo simulations
• Scenario analysis
• Sensitivity analysis
• Export of valuation calculations into Excel
• Export of valuation results into Excel
• Automatic reports
• Export of all visualizations
• Export/import of projects/pipelines or companies
• Database of drug sales
• Database of drug development parameters (sales curve, costs, timelines, success rates per disease group)
• Database of epidemiological data